Showing results for 'N'
Total number of hits: 19
Click on results for more details:
PDIDN001
Nabumetone
Active compound: 6-methoxy-2-naphthylacetic Acid
Indications: Rheumatoid arthritis; Osteoarthritis
Target: Prostaglandin G/H synthase 2
PDIDN002
Nandrolone decanoate
Active compound: Nandrolone
Indications: Refractory deficient red cell production anemias; Breast carcinoma; Hereditary angioedema; Antithrombin III deficiency; Fibrinogen excess; growth failure and Turner's syndrome (WL1)
Target: Androgen receptor (WL1)
PDIDN003
Nandrolone phenylpropionate
Active compound: Nandrolone
Indications: Breast cancer; Osteoporosis (WL1)
Target: Androgen receptor (WL1)
PDIDN004
NB-355
Active compound: Dopamine
Indications: Parkinson’s disease (PD)
Target: Dopamine receptor
PDIDN005
Nelarabine
Active compound: 9-ß-D-arabinofuranosylguanine
Indications: T-cell acute lymphoblastic leukemia (ALL) and lymphoma (LBL)
Target: DNA
PDIDN006
Nepafenac
Active compound: Amfenac
Indications: Pain and inflammation
Target: Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2)
PDIDN007
Nicomorphine
Active compound: Morphine
Indications: Na
Target: mu-type opioid receptor
PDIDN008
Nicotinamide
Active compound: N-methylnicotinamide
Indications: Anticoagulant; Peeling red skin; Niacin deficiency; Acne
Target: Platelet p2y12 receptor
PDIDN009
Nilestriol
Active compound: Ethinylestriol
Indications: Post-menopausal Osteoporosis
Target: Androgen receptor
PDIDN010
Norethisterone acetate
Active compound: Norethisterone
Indications: Amenorrhea, functional uterine bleeding, endometriosis, and for contraception (Ref 1)
Target: Progesterone receptor (Ref 2)
PDIDN011
Norfloxacin prodrug of stavudine
Active compound: Stavudine
Indications: Tuberculosis
Target: Reverse transcriptase/RnaseH
PDIDN012
Norgestimate
Active compound: Levonorgestrel-17- acetate
Indications: Contraception
Target: progesterone receptor
PDIDN012
Norgestimate
Active compound: Levonorgestrel
Indications: Contraception
Target: progesterone receptor
PDIDN013
NSC-606698
Active compound: Rapamycin
Indications: Diabetes mellitus, asthma and rheumatic disorders
Target: na
PDIDN014
NSC-606699
Active compound: Rapamycin
Indications: Na
Target: na
PDIDN015
NSC-606700
Active compound: Rapamycin
Indications: Na
Target: na
PDIDN016
NSC643812
Active compound: Combretastatin
Indications: cancer
Target: Tubulin
PDIDN017
NSC-731657
Active compound: STAVUDINE
Indications: HIV infection
Target: Reverse Transcriptase
PDIDN018
NSC-731658
Active compound: STAVUDINE
Indications: HIV infection
Target: Reverse Transcriptase